HWHG(SH:600079) Shang Hai Zheng Quan Bao·2025-12-05 19:43Group 1 - The board of directors of Renfu Pharmaceutical Group Co., Ltd. held its fourth meeting of the eleventh session on December 5, 2025, with all nine directors present, ensuring compliance with legal and regulatory requirements [2][4] - The board approved the establishment of a supervision department to enhance internal supervision, improve compliance governance, and mitigate integrity risks, thereby ensuring effective execution of the company's strategic decisions [3] - The board also approved the formulation of the "Risk Management and Internal Control Management System" and the "Legal Compliance Affairs Management System," both of which will be disclosed on the Shanghai Stock Exchange website [5][6] Group 2 - All resolutions passed with unanimous support, receiving 9 votes in favor, with no votes against or abstentions [4][5][6] - The establishment of the supervision department and the new management systems reflect the company's commitment to stringent governance and risk management practices [3][5][6] - The meeting was chaired by Chairman Deng Weidong, indicating strong leadership and oversight within the company [2]